Medtronic Adds Smart Insulin Pen By Acquiring Companion Medical

The deal is part of Medtronic's ongoing strategy to revive its diabetes business with technology that simplifies insulin delivery. 

Insulin molecules. Insulin is a protein hormone that regulates the metabolism of carbohydrates and fats. 3d rendering
Insulin Molecules • Source: shutterstock.com

Medtronic plc is adding the InPen “smart” insulin pen to its diabetes portfolio by acquiring Companion Medical for an undisclosed price.

“This acquisition is an ideal strategic fit for Medtronic as we further simplify diabetes management and improve outcomes by optimizing...

Medtech Insight Podcast

Keep up with the top medtech business and regulatory news.

Medtech Insight brings you interviews and analysis, on the go.

More from Deals

More from Business